Article Versions Notes

McConnell YJ, Farshidfar F, Weljie AM, Kopciuk KA, Dixon E, Ball CG, Sutherland FR, Vogel HJ, Bathe OF. Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry. Metabolites. 2017; 7(1):3. https://doi.org/10.3390/metabo7010003

McConnell, Yarrow J., Farshad Farshidfar, Aalim M. Weljie, Karen A. Kopciuk, Elijah Dixon, Chad G. Ball, Francis R. Sutherland, Hans J. Vogel, and Oliver F. Bathe. 2017. "Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry" Metabolites 7, no. 1: 3. https://doi.org/10.3390/metabo7010003

McConnell, Y. J., Farshidfar, F., Weljie, A. M., Kopciuk, K. A., Dixon, E., Ball, C. G., Sutherland, F. R., Vogel, H. J., & Bathe, O. F. (2017). Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry. Metabolites, 7(1), 3. https://doi.org/10.3390/metabo7010003